Nociceptin/orphanin FQ (N/OFQ) was recently identified as the endogenous li
gand for the opioid-receptor like (ORL1) receptor. Although the ORL1 recept
or shows sequence homology with the opioid receptors, the nociceptin/ORL1 l
igand-receptor system has very distinct pharmacological actions compared to
the opioid receptor system. Recently, several small-molecule ORL1 receptor
ligands were reported by pharmaceutical companies. Most of these ligands h
ad close structural similarities with known neuroleptics and opiates. In th
is study, we screened several available neuroleptics and opiates for their
binding affinity and functional activity at ORL1 and the opioid receptors.
We also synthesized several analogs of known opiates with modified piperidi
ne N-substituents in order to characterize the ORL1 receptor ligand binding
pocket. Substitution with the large, lipophilic cyclooctylmethyl moiety in
creased ORL1 receptor affinity and decreased mu receptor affinity and effic
acy in the fentanyl series of ligands but had a different effect in the ori
pavine class of opiate ligands. Our results indicate that opiates and neuro
leptics may be good starting points for ORL1 receptor ligand design, and th
e selectivity may be modulated by appropriate structural modifications. (C)
2001 Elsevier Science B.V. All rights reserved.